CB
HRTX icon

CNB Bank’s Heron Therapeutics HRTX Stock Holding History

CNB Bank’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-500
Closed -$630 – 513
2025
Q3 		$630 Hold
500
– – ﹤0.01% 493
2025
Q2 		$1.03K Hold
500
– – ﹤0.01% 472
2025
Q1 		$1.1K Hold
500
– – ﹤0.01% 455
2024
Q4 		$765 Hold
500
– – ﹤0.01% 469
2024
Q3 		$995 Hold
500
– – ﹤0.01% 494
2024
Q2 		$1.75K Hold
500
– – ﹤0.01% 481
2024
Q1 		$1.39K Hold
500
– – ﹤0.01% 470
2023
Q4 		$850 Hold
500
– – ﹤0.01% 464
2023
Q3 		$515 Hold
500
– – ﹤0.01% 483
2023
Q2 		$580 Hold
500
– – ﹤0.01% 430
2023
Q1 		$755 Hold
500
– – ﹤0.01% 464
2022
Q4 		$1.25K Hold
500
– – ﹤0.01% 426
2022
Q3 		$2K Buy
+500
New +$1.96K ﹤0.01% 419

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

CNB Bank's HRTX Position: Q4 2025 in Review

CNB Bank sold out of Heron Therapeutics (HRTX) in Q4 2025, closing a stake of 500 shares — an estimated $630 sold.

CNB Bank first reported a position in HRTX in Q3 2022 and held it in 13 quarters. The position peaked at $2K in Q3 2022. 170 funds tracked by Wall St. Rank hold HRTX as of Q4 2025.

  • CNB Bank reported no remaining Heron Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CNB Bank sold 500 Heron Therapeutics shares in Q4 2025, an estimated $630.
  • CNB Bank first reported a position in Heron Therapeutics in Q3 2022 and held it in 13 quarters.
  • CNB Bank's Heron Therapeutics position peaked at $2K in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2025.

Based on CNB Bank's 13F filing for Q4 2025, filed 11 Feb 2026.